Junfeng Wu, Ph.D. - Publications
Affiliations: | 2010 | Boston University, Boston, MA, United States |
Area:
BiochemistryYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Bergholz J, Zhang Y, Wu J, Meng L, Walsh EM, Rai A, Sherman MY, Jim Xiao ZX. ΔNp63α regulates Erk signaling via MKP3 to inhibit cancer metastasis Oncogene. 33: 212-224. PMID 23246965 DOI: 10.1038/Onc.2012.564 | 0.322 | |||
2013 | Du W, Yi Y, Zhang H, Bergholz J, Wu J, Ying H, Zhang Y, Xiao ZX. Rapamycin inhibits IGF-1-mediated up-regulation of MDM2 and sensitizes cancer cells to chemotherapy. Plos One. 8: e63179. PMID 23638184 DOI: 10.1371/Journal.Pone.0063179 | 0.329 | |||
2010 | Wu J, Bergholz J, Lu J, Sonenshein GE, Xiao ZX. TAp63 is a transcriptional target of NF-kappaB. Journal of Cellular Biochemistry. 109: 702-10. PMID 20052674 DOI: 10.1002/Jcb.22449 | 0.447 | |||
2009 | Du W, Wu J, Walsh EM, Zhang Y, Chen CY, Xiao ZX. Nutlin-3 affects expression and function of retinoblastoma protein: role of retinoblastoma protein in cellular response to nutlin-3. The Journal of Biological Chemistry. 284: 26315-21. PMID 19648117 DOI: 10.1074/Jbc.M109.046904 | 0.325 | |||
2008 | Qiu W, Wu J, Walsh EM, Zhang Y, Chen CY, Fujita J, Xiao ZXJ. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells Oncogene. 27: 4034-4043. PMID 18332869 DOI: 10.1038/Onc.2008.43 | 0.315 | |||
Show low-probability matches. |